These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 17907768)

  • 21. Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles.
    Li M; Zou P; Tyner K; Lee S
    AAPS J; 2017 Jan; 19(1):26-42. PubMed ID: 27834047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of drug disposition on the basis of its chemical structure.
    Stepensky D
    Clin Pharmacokinet; 2013 Jun; 52(6):415-31. PubMed ID: 23463353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches.
    Guo Y; Chu X; Parrott NJ; Brouwer KLR; Hsu V; Nagar S; Matsson P; Sharma P; Snoeys J; Sugiyama Y; Tatosian D; Unadkat JD; Huang SM; Galetin A;
    Clin Pharmacol Ther; 2018 Nov; 104(5):865-889. PubMed ID: 30059145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming the shortcomings of the extended-clearance concept: a framework for developing a physiologically-based pharmacokinetic (PBPK) model to select drug candidates involving transporter-mediated clearance.
    Liang X; Lai Y
    Expert Opin Drug Metab Toxicol; 2021 Aug; 17(8):869-886. PubMed ID: 33793347
    [No Abstract]   [Full Text] [Related]  

  • 25. Measurement of disposition half-life, clearance, and residence times.
    Mayersohn M
    Curr Protoc Toxicol; 2001 May; Chapter 5():Unit5.3. PubMed ID: 20949436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simulation of differential drug pharmacokinetics under heat and exercise stress using a physiologically based pharmacokinetic modeling approach.
    Sidhu P; Peng HT; Cheung B; Edginton A
    Can J Physiol Pharmacol; 2011 May; 89(5):365-82. PubMed ID: 21627485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the Change in the Blood Concentration-Time Profile Caused by Complex Drug-Drug Interactions in the Liver Considering the Enterohepatic Circulation: Examining Whether the Inhibition Constants for Uptake, Metabolism, and Biliary Excretion Can be Recovered by the Analyses Using Physiologically Based Pharmacokinetic Modeling.
    Toshimoto K; Tomoda Y; Chiba K; Sugiyama Y
    J Pharm Sci; 2017 Sep; 106(9):2727-2738. PubMed ID: 28479365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploration of PBPK Model-Calculation of Drug Time Course in Tissue Using IV Bolus Drug Plasma Concentration-Time Profile and the Physiological Parameters of the Organ.
    Berezhkovskiy LM
    J Pharm Sci; 2016 Aug; 105(8):2453-8. PubMed ID: 27290628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution Clearance: Significance and Underlying Mechanisms.
    Weiss M
    Pharm Res; 2024 Jul; 41(7):1391-1400. PubMed ID: 38981900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved Human Pharmacokinetic Prediction of Hepatically Metabolized Drugs With Species-Specific Systemic Clearance.
    Horiuchi K; Ohnishi S; Matsuzaki T; Funaki S; Watanabe A; Mizutare T; Matsumoto S; Nezasa KI; Hasegawa H
    J Pharm Sci; 2018 May; 107(5):1443-1453. PubMed ID: 29331382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of the possibility of the secondary peaks of iv bolus drug plasma concentration time curve by the model that directly takes into account the transit time through the organ.
    Berezhkovskiy LM
    J Pharm Sci; 2009 Nov; 98(11):4376-90. PubMed ID: 19340884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modelling.
    Jones HM; Gardner IB; Collard WT; Stanley PJ; Oxley P; Hosea NA; Plowchalk D; Gernhardt S; Lin J; Dickins M; Rahavendran SR; Jones BC; Watson KJ; Pertinez H; Kumar V; Cole S
    Clin Pharmacokinet; 2011 May; 50(5):331-47. PubMed ID: 21456633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic changes in critical illness.
    Boucher BA; Wood GC; Swanson JM
    Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro measurements of metabolism for application in pharmacokinetic modeling.
    Lipscomb JC; Poet TS
    Pharmacol Ther; 2008 Apr; 118(1):82-103. PubMed ID: 18374419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models.
    Varma MV; El-Kattan AF
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S99-S109. PubMed ID: 27385183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption.
    Tam D; Tirona RG; Pang KS
    Drug Metab Dispos; 2003 Apr; 31(4):373-83. PubMed ID: 12642462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A whole-body physiologically based pharmacokinetic model incorporating dispersion concepts: short and long time characteristics.
    Oliver RE; Jones AF; Rowland M
    J Pharmacokinet Pharmacodyn; 2001 Feb; 28(1):27-55. PubMed ID: 11253612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a hybrid physiologically based pharmacokinetic model with drug-specific scaling factors in rat to improve prediction of human pharmacokinetics.
    Sayama H; Komura H; Kogayu M; Iwaki M
    J Pharm Sci; 2013 Nov; 102(11):4193-204. PubMed ID: 24018828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
    Lüpfert C; Reichel A
    Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologically based structure of mean residence time.
    Durišová M
    ScientificWorldJournal; 2012; 2012():610631. PubMed ID: 22566773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.